Literature DB >> 2949253

[Treatment of Argentine hemorrhagic fever with convalescent's plasma. 4433 cases].

H A Ruggiero, F Pérez Isquierdo, H A Milani, A Barri, A Val, F Maglio, L Astarloa, C Gonzalez Cambaceres, H L Milani, J C Tallone.   

Abstract

During the 23 consecutive annual epidemics of Argentine haemorrhagic fever observed from 1959 to 1983, a group of 4,433 patients were treated at Junin (Argentina) with convalescent's plasma; the overall mortality rate was 3.29%. In 1958, before convalescent's plasma was used, the mortality rate in 448 patients who received the conventional treatment was 42.85%. The difference between the two groups is highly significant and demonstrates the value of convalescent's plasma in the treatment of the disease.

Entities:  

Mesh:

Year:  1986        PMID: 2949253

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  22 in total

Review 1.  Convalescent plasma: new evidence for an old therapeutic tool?

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Liviana Catalano; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

2.  Genetic diversity among Bolivian arenaviruses.

Authors:  Maria N B Cajimat; Mary Louise Milazzo; Pierre E Rollin; Stuart T Nichol; Michael D Bowen; Thomas G Ksiazek; Charles F Fulhorst
Journal:  Virus Res       Date:  2008-12-19       Impact factor: 3.303

Review 3.  Native functionality and therapeutic targeting of arenaviral glycoproteins.

Authors:  Max Crispin; Antra Zeltina; Nicole Zitzmann; Thomas A Bowden
Journal:  Curr Opin Virol       Date:  2016-04-19       Impact factor: 7.090

4.  Molecular Basis for Antibody-Mediated Neutralization of New World Hemorrhagic Fever Mammarenaviruses.

Authors:  Selma Mahmutovic; Lars Clark; Silvana C Levis; Ana M Briggiler; Delia A Enria; Stephen C Harrison; Jonathan Abraham
Journal:  Cell Host Microbe       Date:  2015-12-09       Impact factor: 21.023

5.  Genetic diversity between and within the arenavirus species indigenous to western Venezuela.

Authors:  Charles F Fulhorst; Maria N B Cajimat; Mary Louise Milazzo; Hector Paredes; Nuris M C de Manzione; Rosa A Salas; Pierre E Rollin; Thomas G Ksiazek
Journal:  Virology       Date:  2008-06-30       Impact factor: 3.616

Review 6.  Clinical Management of COVID-19: A Review of Pharmacological Treatment Options.

Authors:  Ashli M Heustess; Melissa A Allard; Dorothea K Thompson; Pius S Fasinu
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-28

Review 7.  COVID-19 challenges and its therapeutics.

Authors:  Sabi Ur Rehman; Shaheed Ur Rehman; Hye Hyun Yoo
Journal:  Biomed Pharmacother       Date:  2021-08-05       Impact factor: 6.529

Review 8.  Junín virus pathogenesis and virus replication.

Authors:  Ashley Grant; Alexey Seregin; Cheng Huang; Olga Kolokoltsova; Allan Brasier; Clarence Peters; Slobodan Paessler
Journal:  Viruses       Date:  2012-10-19       Impact factor: 5.048

9.  Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection.

Authors:  Francisca Valdivieso; Pablo Vial; Marcela Ferres; Chunyan Ye; Diane Goade; Analia Cuiza; Brian Hjelle
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

10.  RIG-I enhanced interferon independent apoptosis upon Junin virus infection.

Authors:  Olga A Kolokoltsova; Ashley M Grant; Cheng Huang; Jennifer K Smith; Allison L Poussard; Bing Tian; Allan R Brasier; Clarence J Peters; Chien-Te Kent Tseng; Juan C de la Torre; Slobodan Paessler
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.